Grifols Board of Directors Announces Termination of Acquisition ...
4 天之前 · Barcelona, Spain, Nov. 27, 2024 – The Board of Directors of Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced the termination of discussions with Brookfield Capital Partners (UK) Limited (“Brookfield”) regarding a potential acquisition of Grifols shares.
Grifols shares tumble after Brookfield drops takeover plan
4 天之前 · Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at 6.45 billion euros ($6.79 billion), which Grifols then said was a ...
Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols
4 天之前 · Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over the Spanish blood-plasma company. The New York-based money manager said ...
Brookfield Set to Drop Grifols Bid as Family Shuns Others
4 天之前 · The decision to drop the bid comes just days after the Grifols board rejected an indicative price offer from the asset manager that valued the company at €6.45 billion ($6.8 billion).
Grifols shares sink after Brookfield walks away from €6.45bn offer
4 天之前 · Grifols’ bond prices also fell on news of Brookfield stepping away from a bid, with its debt maturing in 2028 falling four percentage points to 89 cents on the euro, a significant discount to ...
Billionaire Grifols Family’s Woes in Focus After Brookfield Exit
3 天之前 · For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical fortunes, Brookfield Asset Management’s plan to take its troubled ...
Grifols In Talks to Refinance Debt, Credit Line, CEO Says
3 天之前 · The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving credit line — together about €1.4 billion ($1.48 billion) — as it ...
Press Releases - Grifols.com
2024年7月25日 · Financial and regulatory information for investors and shareholders.
Grifols says founding family, Brookfield looking to delist drugmaker
2024年7月9日 · The Grifols family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols with the intent to delist it, the companies said...
Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (3)
2024年11月19日 · Grifols SA ’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).. The offer “significantly undervalues the company’s fundamental prospects and its long-term potential,” Grifols said in a regulatory filing on Tuesday. The asset manager’s disclosure was a tentative, non ...